We are live on ! Find out more
RDVT icon

Red Violet

20 hedge funds and large institutions have $9.8M invested in Red Violet in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,613% more capital inflows, than outflows

Capital inflows: $2.42M | Capital outflows: $141K

3.05% more ownership

Funds ownership: 11.12% → 14.17% (+3.1%)

9% less funds holding

Funds holding: 22 → 20 (-2)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RDVT Hedge Fund Activity: Q1 2019 in Review

20 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in Red Violet (RDVT) for Q1 2019, worth a combined $9.8M — up 27% from $7.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of RDVT and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Wellington Management Group, adding an estimated $1.33M. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $69K sold.

  • 20 institutional investors held Red Violet (RDVT) as of Q1 2019, down from 22 in Q4 2018.
  • Funds reported $9.8M of Red Violet stock for Q1 2019, up 27% quarter-over-quarter.
  • 3 funds opened new Red Violet positions in Q1 2019 and 5 closed out, a net change of -2 holders.
  • The largest Red Violet buyer in Q1 2019 was Wellington Management Group, an estimated $1.33M added.
  • The largest Red Violet seller in Q1 2019 was Cambridge Investment Research Advisors, an estimated $69K sold.

Based on aggregated 13F filings for Q1 2019.